A Safety, Tolerability, PD and PK Study in Healthy Adults
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety, tolerability, pharmacodynamics
(PD) and pharmacokinetics (PK) of TRV734 given as a single dose (Part A) and as multiple
ascending doses (Part B) in healthy subjects.